ALPHATEC HOLDINGS, INC. Operating Cash Flow
ALPHATEC HOLDINGS, INC. (ATEC) reported Operating Cash Flow of $21.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $20.51M, a 31.93% increase year-over-year.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $1.29M.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $20.68M, a 96.54% increase year-over-year.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $14.04M.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $45.23M.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$44.65M.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$78.48M.
- ALPHATEC HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$75.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $21.80M 10-Q · filed 2026-08-04 | $42.48M derived: sum of 3 quarters · filed 2026-08-04 | $56.52M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-05 | $21.97M derived: sum of 2 quarters · filed 2026-05-05 | $36.01M derived: sum of 3 quarters · filed 2026-05-05 | $51.56M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $20.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $34.72M derived: sum of 2 quarters · filed 2026-02-24 | $50.27M derived: sum of 3 quarters · filed 2026-08-04 | $45.23M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $14.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $29.59M derived: sum of 2 quarters · filed 2026-08-04 | $24.55M 10-Q · filed 2025-10-30 | $35.07M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $15.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.51M 10-Q · filed 2026-08-04 | $21.03M derived: sum of 3 quarters · filed 2026-08-04 | $15.69M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$5.04M 10-Q · filed 2026-05-05 | $5.48M derived: sum of 2 quarters · filed 2026-05-05 | $142.00K derived: sum of 3 quarters · filed 2026-05-05 | -$11.25M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.18M derived: sum of 2 quarters · filed 2026-02-24 | -$6.21M derived: sum of 3 quarters · filed 2026-02-24 | -$44.65M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$5.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$16.74M derived: sum of 2 quarters · filed 2025-10-30 | -$55.17M 10-Q · filed 2025-10-30 | -$80.18M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$11.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$49.83M 10-Q · filed 2025-07-31 | -$74.84M derived: sum of 3 quarters · filed 2026-02-24 | -$92.12M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$38.44M 10-Q · filed 2025-05-01 | -$63.44M derived: sum of 2 quarters · filed 2026-02-24 | -$80.73M derived: sum of 3 quarters · filed 2026-02-24 | -$98.60M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$42.29M derived: sum of 2 quarters · filed 2026-02-24 | -$60.16M derived: sum of 3 quarters · filed 2026-02-24 | -$78.48M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$17.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$35.16M derived: sum of 2 quarters · filed 2024-10-30 | -$53.48M 10-Q · filed 2024-10-30 | -$61.88M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | -$17.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$36.20M 10-Q · filed 2024-07-31 | -$44.60M derived: sum of 3 quarters · filed 2025-02-26 | -$59.29M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | -$18.32M 10-Q · filed 2024-05-07 | -$26.73M derived: sum of 2 quarters · filed 2025-02-26 | -$41.42M derived: sum of 3 quarters · filed 2025-02-26 | -$68.75M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | -$8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$23.09M derived: sum of 2 quarters · filed 2025-02-26 | -$50.43M derived: sum of 3 quarters · filed 2025-02-26 | -$75.13M 10-K · filed 2025-02-26 | -$75.14M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$14.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$42.03M derived: sum of 2 quarters · filed 2023-11-06 | -$66.73M 10-Q · filed 2023-11-06 | -$66.74M 10-Q · filed 2022-11-03 | -$81.47M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | -$27.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$52.04M 10-Q · filed 2023-08-03 | -$52.05M 10-Q · filed 2022-08-04 | -$66.78M derived: sum of 3 quarters · filed 2024-02-27 | -$90.25M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | -$24.70M 10-Q · filed 2023-05-04 | -$24.71M 10-Q · filed 2022-05-05 | -$39.45M derived: sum of 2 quarters · filed 2024-02-27 | -$62.91M derived: sum of 3 quarters · filed 2024-02-27 | -$79.42M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | -$14.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$38.21M derived: sum of 2 quarters · filed 2024-02-27 | -$54.71M derived: sum of 3 quarters · filed 2024-02-27 | -$73.32M 10-K · filed 2024-02-27 | -$73.43M 10-K · filed 2022-03-02 | |||
| 2021-09-30 | -$23.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$39.97M derived: sum of 2 quarters · filed 2022-11-03 | -$58.58M 10-Q · filed 2022-11-03 | -$65.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$16.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$35.11M 10-Q · filed 2022-08-04 | -$41.84M derived: sum of 3 quarters · filed 2023-02-28 | -$51.38M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$18.60M 10-Q · filed 2022-05-05 | -$25.33M derived: sum of 2 quarters · filed 2023-02-28 | -$34.87M derived: sum of 3 quarters · filed 2023-02-28 | -$47.97M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$16.27M derived: sum of 2 quarters · filed 2023-02-28 | -$29.36M derived: sum of 3 quarters · filed 2023-02-28 | -$46.41M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$22.64M derived: sum of 2 quarters · filed 2021-11-04 | -$39.68M 10-Q · filed 2021-11-04 | -$48.75M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$13.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$30.14M 10-Q · filed 2021-08-03 | -$39.21M derived: sum of 3 quarters · filed 2021-08-03 | -$48.62M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | -$17.05M 10-Q · filed 2021-05-06 | -$26.11M derived: sum of 2 quarters · filed 2021-05-06 | -$35.53M derived: sum of 3 quarters · filed 2021-05-06 | -$42.23M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$9.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$18.48M derived: sum of 2 quarters · filed 2021-03-05 | -$25.18M derived: sum of 3 quarters · filed 2021-03-05 | -$33.12M 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | -$9.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$16.11M derived: sum of 2 quarters · filed 2020-11-05 | -$24.05M 10-Q · filed 2020-11-05 | -$33.14M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$14.64M 10-Q · filed 2020-08-06 | -$23.73M derived: sum of 3 quarters · filed 2020-08-06 | -$31.54M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$7.94M 10-Q · filed 2020-05-11 | -$17.03M derived: sum of 2 quarters · filed 2020-05-11 | -$24.84M derived: sum of 3 quarters · filed 2020-05-11 | -$28.25M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$16.90M derived: sum of 2 quarters · filed 2020-03-17 | -$20.31M derived: sum of 3 quarters · filed 2020-03-17 | -$25.61M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$7.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$11.22M derived: sum of 2 quarters · filed 2019-11-01 | -$16.52M 10-Q · filed 2019-11-01 | -$17.14M derived: sum of 4 quarters · filed 2019-11-01 | ||||
| 2018-06-30 | -$3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$8.71M 10-Q · filed 2019-07-26 | -$9.33M derived: sum of 3 quarters · filed 2019-07-26 | -$10.96M derived: sum of 4 quarters · filed 2019-07-26 | ||||
| 2018-03-31 | -$5.30M 10-Q · filed 2019-05-10 | -$5.92M derived: sum of 2 quarters · filed 2019-05-10 | -$7.55M derived: sum of 3 quarters · filed 2019-05-10 | -$7.98M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$615.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$2.25M derived: sum of 2 quarters · filed 2019-03-29 | -$2.68M derived: sum of 3 quarters · filed 2019-03-29 | -$8.73M 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$2.06M derived: sum of 2 quarters · filed 2018-11-09 | -$8.11M 10-Q · filed 2018-11-09 | -$17.95M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$6.47M 10-Q · filed 2018-08-03 | -$16.31M derived: sum of 3 quarters · filed 2018-08-03 | -$26.51M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$6.05M 10-Q · filed 2018-05-11 | -$15.88M derived: sum of 2 quarters · filed 2018-05-11 | -$26.08M derived: sum of 3 quarters · filed 2018-05-11 | -$16.22M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$20.03M derived: sum of 2 quarters · filed 2018-03-09 | -$10.17M derived: sum of 3 quarters · filed 2018-03-09 | -$9.96M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$336.00K derived: sum of 2 quarters · filed 2017-11-09 | -$126.00K 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $9.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $10.07M 10-Q · filed 2017-08-11 | ||||||
| 2016-03-31 | $210.00K 10-Q · filed 2017-05-12 | |||||||
| 2015-12-31 | $10.12M 10-K · filed 2017-03-31 | |||||||
| 2014-12-31 | -$20.27M 10-K · filed 2017-03-31 | |||||||
| 2013-12-31 | $7.81M 10-K · filed 2016-03-15 | |||||||
| 2013-03-31 | -$336.00K 10-Q · filed 2013-05-02 | -$634.00K derived: sum of 2 quarters · filed 2015-02-27 | $7.68M derived: sum of 3 quarters · filed 2015-02-27 | $12.69M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.02M derived: sum of 2 quarters · filed 2015-02-27 | $13.02M derived: sum of 3 quarters · filed 2015-02-27 | $11.59M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $8.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $13.32M derived: sum of 2 quarters · filed 2012-11-06 | $11.89M 10-Q · filed 2012-11-06 | $14.19M derived: sum of 4 quarters · filed 2014-03-20 | ||||
| 2012-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $3.57M 10-Q · filed 2012-08-08 | $5.87M derived: sum of 3 quarters · filed 2014-03-20 | $12.43M derived: sum of 4 quarters · filed 2014-03-20 | ||||
| 2012-03-31 | -$1.43M 10-Q · filed 2013-05-02 | $868.00K derived: sum of 2 quarters · filed 2014-03-20 | $7.42M derived: sum of 3 quarters · filed 2014-03-20 | $10.37M derived: sum of 4 quarters · filed 2014-03-20 | ||||
| 2011-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $8.85M derived: sum of 2 quarters · filed 2014-03-20 | $11.80M derived: sum of 3 quarters · filed 2014-03-20 | $13.41M 10-K · filed 2014-03-20 | ||||
| 2011-09-30 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $9.50M derived: sum of 2 quarters · filed 2012-11-06 | $11.11M 10-Q · filed 2012-11-06 | $9.43M derived: sum of 4 quarters · filed 2013-03-05 | ||||
| 2011-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $4.56M 10-Q · filed 2012-08-08 | $2.88M derived: sum of 3 quarters · filed 2013-03-05 | $971.00K derived: sum of 4 quarters · filed 2013-03-05 | ||||
| 2011-03-31 | $1.61M 10-Q · filed 2012-05-08 | -$68.00K derived: sum of 2 quarters · filed 2013-03-05 | -$1.97M derived: sum of 3 quarters · filed 2013-03-05 | |||||
| 2010-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | -$3.58M derived: sum of 2 quarters · filed 2013-03-05 | -$14.83M 10-K · filed 2013-03-05 | |||||
| 2010-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$13.15M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$11.25M 10-Q · filed 2011-08-08 | |||||||
| 2009-12-31 | -$5.55M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |